Mul­tiTox Seminar & Sym­po­sium

Beauty Cosmedica Singapore - - Beauty Scene -

VENUE: Sun­tec Sin­ga­pore Con­ven­tion & Ex­hi­bi­tion Cen­tre

DATE: 9 May 2015

Hosted by Aes­thetic Mar­ket­ing, doc­tors and aes­thetic pro­fes­sion­als were in­vited to the Mul­tiTox Seminar & Sym­po­sium, which high­lighted the launch of the Mul­tiTox, a state-of-the-art cra­dle for the Bo­tulinum sy­ringe, which may help the at­ten­dees of the sym­po­sium to ex­pand their pro­fes­sional prac­tices and pro­vide im­proved treat­ment re­sults for their pa­tients.

Head­lin­ing the seminar and sym­po­sium was Dr. Tsahi Vider, M.D., a renowned gen­eral sur­geon as well as owner and CEO of O-R Clin­ics and founder of In­jecTec. De­vel­oped and in­tro­duced by In­jecTec, the Mul­tiTox is a highly ef­fi­cient cra­dle for multi-pur­pose in­jec­tions, which ad­dresses the need for ac­cu­racy, pre­cise place­ment, and ex­act dosages re­quired dur­ing Bo­tulinum Toxin (Bo­tox) pro­ce­dures – which sy­ringes to­day can­not achieve. Dr. Tsahi Vider shared his in­sights on how Mul­tiTox can rev­o­lu­tion­ize the Bo­tox treat­ment as it of­fers metic­u­lous at­ten­tion to com­fort and safety, thus im­prov­ing the pa­tient's over­all ex­pe­ri­ence. Cost-ef­fec­tive and highly pre­cise, the Mul­tiTox de­creases the risks of asym­met­ri­cal re­sults and elim­i­nates over-in­jec­tion or spillage. The sym­po­sium came to a close with a com­pre­hen­sive Q&A ses­sion be­tween Dr. Tsahi Vider and the at­ten­dees of the event.

Newspapers in English

Newspapers from Singapore

© PressReader. All rights reserved.